Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2015 Nov 18;3:258. doi: 10.3389/fpubh.2015.00258

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

Copyright © 2015 Chen, Ling, Lin, He and Guan.

This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

PMC Copyright notice

Comparison of Recormon vs. Epiao in the treatment of anemia. (A) Patients treated with Recormon and Epiao had similar hemoglobin levels (103.54 ± 1.72 g/L, n = 98 vs. 102.59 ± 1.38 g/L, n = 142, P > 0.05). (B) The dosage of Recormon for anemia treatment was significantly less than Epiao, 3,853.66 ± 225.13 μ/week, n = 98 vs. 7,083.33 ± 264.93 μ/week, n = 142. (C–E) There were no significant differences in calcium (C), phosphorus (D), and albumin (E) levels between the Recormon and Epiao groups. Data were calculated by t-test; P > 0.05.